GlassScriptPhysician profile
Leanne Pereira
NPI 1316567001
$981.79
in general payments reported to CMS, 2019-2025
11 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $120 · 2021: $148 · 2022: $15.46 · 2023: $264 · 2024: $203 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.59 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $208.79 | 2024-2025 | Camzyos, Eliquis |
| Astellas Pharma US INC | $198.00 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.51 | 2021-2024 | Jardiance |
| Esperion Therapeutics, INC. | $120.25 | 2020 | |
| Pfizer INC. | $119.23 | 2023-2024 | |
| Lantheus Medical Imaging, INC. | $70.66 | 2023-2025 | Definity |
| Astrazeneca Pharmaceuticals LP | $31.47 | 2025 | |
| Edwards Lifesciences Corporation | $28.25 | 2021 | |
| Novo Nordisk INC | $24.17 | 2025 | Ozempic |
| Merck Sharp & Dohme LLC | $18.00 | 2025 | Winrevair |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanne Pereira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.